5-Flurouracil disrupts nuclear export and nuclear pore permeability in a calcium dependent manner

Kelly J Higby1,2, Melissa M Bischak1,3, Christina A Campbell1,4

  • 1Department of Biology Hoyt Science Center 222, Westminster College, 319 S Market Street, New Wilmington, PA, 16172, USA.

Insights

5-Fluorouracil (5-FU) disrupts nuclear transport and increases nuclear pore complex (NPC) permeability via calcium, independent of caspase activation. This mechanism enhances chemotherapy efficacy by retaining tumor suppressors in the nucleus.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Pharmacology

Background:

  • Nuclear transport regulation is crucial for apoptosis and is disrupted by chemotherapy.
  • The effects of 5-Fluorouracil (5-FU) and camptothecins on nuclear pore complex (NPC) function during apoptosis are not fully understood.
  • Crm1-mediated nuclear export of tumor suppressors is implicated in drug resistance.

Purpose of the Study:

  • To characterize the general effects of 5-FU, topotecan, and irinotecan on NPC and nuclear transport during apoptosis.
  • To investigate the role of calcium and caspase activation in 5-FU-induced nuclear transport alterations.
  • To examine the impact of 5-FU on the nuclear export of topoisomerase and p53, and its implications for drug resistance.

Main Methods:

  • Assessed NPC permeability and Ran-mediated nuclear transport in response to 5-FU, topotecan, and irinotecan.
  • Utilized the calcium chelator BAPTA-AM to investigate the role of cellular calcium.
  • Examined nuclear accumulation of topoisomerase and p53 following drug treatments.

Main Results:

  • 5-FU, but not topotecan, increased NPC permeability and disrupted Ran-mediated transport before NPC disassembly, dependent on increased cellular calcium.
  • Increased calcium alone disrupted the Ran gradient.
  • Combination treatments with 5-FU and camptothecins disrupted nuclear transport before NPC disassembly and caspase 9 activation, indicating an early, caspase-independent mechanism.
  • 5-FU promoted nuclear accumulation of topoisomerase, counteracting the loss induced by irinotecan/topotecan, and retained p53 nuclear accumulation in combination treatments.

Conclusions:

  • 5-FU induces an early, calcium-dependent, caspase-independent increase in NPC permeability and alters nuclear transport.
  • 5-FU enhances chemotherapy efficacy by inhibiting Crm1-mediated nuclear export of tumor suppressors like topoisomerase and p53.
  • These findings reveal a novel mechanism of action for 5-FU in apoptosis and suggest potential for novel combination chemotherapies.

Related Concept Videos

Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
5.1K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.4K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60
Directionality of Nuclear Transport01:42

Directionality of Nuclear Transport

Ras-related nuclear protein or Ran is a small G protein that cycles between its GTP and GDP bound states. Ran specific regulators, a Ran GTPase Activating Protein or RanGAP present in the cytosol and a Ran guanine nucleotide exchange factor or RanGEF present inside the nucleus regulate GTP/GDP exchange. A high concentration of GTP inside the cells, in addition to this asymmetric distribution of  Ran-specific regulators, leads to a higher RanGTP concentration inside the nucleus. This...
4.8K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
9.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K